Facilitators and barriers to implementing successful exclusion among children with shiga toxin-producing Escherichia coli: a qualitative analysis of public health case management records.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
21 Aug 2024
Historique:
received: 30 10 2023
accepted: 24 07 2024
medline: 22 8 2024
pubmed: 22 8 2024
entrez: 21 8 2024
Statut: epublish

Résumé

Shiga toxin-producing Escherichia coli (STEC) infections are a significant public health concern as they can cause serious illness and outbreaks. In England, STEC incidence is highest among children and guidance recommends that children under six diagnosed with STEC are excluded from childcare until two consecutive stool cultures are negative. We aimed to describe the barriers and facilitators to implementing exclusion and the impact of exclusion policies on young children and their families. Individual level data was obtained from a wider study focusing on shedding duration among STEC cases aged < 6 years between March 2018 - March 2022. Data was extracted from England's public health case management system. The case management system includes notes on telephone conversations, email correspondence and meeting minutes relating to the case. Collected data consisted of free text in three forms: (1) quotes from parents, either direct or indirect, (2) direct quotes from the case record by health protection practitioners or environmental health officers, and (3) summaries by the data collector after reviewing the entire case record. We analysed free text comments linked to 136 cases using thematic analysis with a framework approach. The median age of included cases was 3 years (IQR 1.5-5), with males accounting for 49%. Nine key themes were identified. Five themes focused on barriers to managing exclusion, including (i) financial losses, (ii) challenges with communication, engagement and collaboration, (iii) issues with sampling, processing, and results, (iv) adverse impact on children and their families and (v) conflicting exclusion advice. Four themes related to facilitators to exclusion, including (i) good communication with parents and childcare settings, (ii) support with childcare, (iii) improvements to sampling, testing, and reporting of results, and (iv) provision of supervised control measures. Qualitative analysis of public health case records can provide evidence-based insights around complex health protection issues to inform public health guidelines. Our analysis highlights the importance of considering wider social and economic consequences of exclusion when developing policies and practices for the management of STEC in children.

Sections du résumé

BACKGROUND BACKGROUND
Shiga toxin-producing Escherichia coli (STEC) infections are a significant public health concern as they can cause serious illness and outbreaks. In England, STEC incidence is highest among children and guidance recommends that children under six diagnosed with STEC are excluded from childcare until two consecutive stool cultures are negative. We aimed to describe the barriers and facilitators to implementing exclusion and the impact of exclusion policies on young children and their families.
METHODS METHODS
Individual level data was obtained from a wider study focusing on shedding duration among STEC cases aged < 6 years between March 2018 - March 2022. Data was extracted from England's public health case management system. The case management system includes notes on telephone conversations, email correspondence and meeting minutes relating to the case. Collected data consisted of free text in three forms: (1) quotes from parents, either direct or indirect, (2) direct quotes from the case record by health protection practitioners or environmental health officers, and (3) summaries by the data collector after reviewing the entire case record. We analysed free text comments linked to 136 cases using thematic analysis with a framework approach.
RESULTS RESULTS
The median age of included cases was 3 years (IQR 1.5-5), with males accounting for 49%. Nine key themes were identified. Five themes focused on barriers to managing exclusion, including (i) financial losses, (ii) challenges with communication, engagement and collaboration, (iii) issues with sampling, processing, and results, (iv) adverse impact on children and their families and (v) conflicting exclusion advice. Four themes related to facilitators to exclusion, including (i) good communication with parents and childcare settings, (ii) support with childcare, (iii) improvements to sampling, testing, and reporting of results, and (iv) provision of supervised control measures.
CONCLUSIONS CONCLUSIONS
Qualitative analysis of public health case records can provide evidence-based insights around complex health protection issues to inform public health guidelines. Our analysis highlights the importance of considering wider social and economic consequences of exclusion when developing policies and practices for the management of STEC in children.

Identifiants

pubmed: 39169284
doi: 10.1186/s12889-024-19580-w
pii: 10.1186/s12889-024-19580-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2272

Informations de copyright

© 2024. The Author(s).

Références

Launders N, Byrne L, Jenkins C, Harker K, Charlett A, Adak GJB. Disease severity of Shiga toxin-producing E. Coli O157 and factors influencing the development of typical haemolytic uraemic syndrome: a retrospective cohort study, 2009–12. 2016;6(1):e009933.
Public health operational. guidance for Shiga toxin-producing Escherichia coli (STEC). 2023.
Snedeker KG, Shaw DJ, Locking ME, Prescott RJ. Primary and secondary cases in Escherichia coliO157 outbreaks: a statistical analysis. BMC Infect Dis. 2009;9(1):1–11.
doi: 10.1186/1471-2334-9-144
Shiga toxin-producing. Escherichia coli (STEC) infection. In: Health Q, editor. 2014.
Communicable Disease Case Reporting and Investigation Protocol. In: Health DoP, editor. 2018.
Dabke G, Le Menach A, Black A, Gamblin J, Palmer M, Boxall N, Booth L. Duration of shedding of Verocytotoxin-producing Escherichia coli in children and risk of transmission in childcare facilities in England. Epidemiol Infect. 2014;142(2):327–34.
pubmed: 23672954 doi: 10.1017/S095026881300109X
Collins A, Fallon U, Cosgrove M, Meagher G, Shuileabhan CN. A 10-year analysis of VTEC microbiological clearance times, in the under-six population of the Midlands. Irel Epidemiol Infect. 2017;145(8):1577–83.
doi: 10.1017/S0950268817000425
Roberts JA, Upton PA, Azene G. Escherichia coli O157:H7; an economic assessment of an outbreak. J Public Health Med. 2000;22(1):99–107.
pubmed: 10774911 doi: 10.1093/pubmed/22.1.99
Notifiable diseases and. causative organisms: how to report. 2024.
Adams NL, Rose TC, Hawker J, Violato M, O’Brien SJ, Barr B, et al. Relationship between socioeconomic status and gastrointestinal infections in developed countries: a systematic review and meta-analysis. PLoS ONE. 2018;13(1):e0191633.
pubmed: 29360884 pmcid: 5779704 doi: 10.1371/journal.pone.0191633
Rose TC, Adams NL, Barr B, Hawker J, O’Brien SJ, Violato M, et al. Socioeconomic status is associated with symptom severity and sickness absence in people with infectious intestinal disease in the UK. BMC Infect Dis. 2017;17:1–9.
doi: 10.1186/s12879-017-2551-1
Vusirikala A, Rowell S, Dabke G, Fox G, Bell J, Manuel R, et al. Shedding and exclusion from childcare in children with Shiga toxin-producing Escherichia coli, 2018–2022. Epidemiol Infect. 2024;152:e42.
pubmed: 38403892 pmcid: 10945940 doi: 10.1017/S095026882400027X
Clarke V, Braun V, Hayfield N. Thematic analysis. Qualitative Psychology: Practical Guide Res Methods. 2015;3:222–48.
Stokel-Walker C. Covid-19: why test and trace will fail without support for self-isolation. BMJ. 2021;372.
Omaleki V, Vo AV, Flores M, Majnoonian A, Le T, Nguyen M, et al. It’s hard for everyone systemic barriers to home confinement to prevent community spread of COVID-19. Translational Behav Med. 2023;13(2):64–72.
doi: 10.1093/tbm/ibac074
Vandrevala T, Alidu L, Hendy J, Shafi S, Ala A. It’s possibly made us feel a little more alienated’: how people from ethnic minority communities conceptualise COVID-19 and its influence on engagement with testing. J Health Serv Res Policy. 2022;27(2):141–50.
pubmed: 34978500 pmcid: 8948536 doi: 10.1177/13558196211054961
Embrett M, Sim SM, Caldwell HA, Boulos L, Yu Z, Agarwal G, et al. Barriers to and strategies to address COVID-19 testing hesitancy: a rapid scoping review. BMC Public Health. 2022;22(1):1–10.
doi: 10.1186/s12889-022-13127-7
Watson D, Baralle NL, Alagil J, Anil K, Ciccognani S, Dewar-Haggart R, et al. How do we engage people in testing for COVID-19? A rapid qualitative evaluation of a testing programme in schools, GP surgeries and a university. BMC Public Health. 2022;22(1):305.
pubmed: 35164728 pmcid: 8842975 doi: 10.1186/s12889-022-12657-4
Johnston BC, Donen R, Pooni A, Pond J, Xie F, Giglia L, et al. Conceptual framework for health-related quality of life assessment in acute gastroenteritis. J Pediatr Gastroenterol Nutr. 2013;56(3):280–9.
pubmed: 23135341 doi: 10.1097/MPG.0b013e3182736f49
Lugg F. The management of paediatric gastroenteritis at home and within UK primary care. Cardiff University. PhD Thesis. 2014.
Srivastava T, Shen AK, Browne S, Michel JJ, Tan AS, Kornides ML. Comparing COVID-19 vaccination outcomes with parental values, beliefs, attitudes, and Hesitancy Status, 2021–2022. Vaccines. 2022;10(10):1632.
pubmed: 36298497 pmcid: 9611997 doi: 10.3390/vaccines10101632
Taylor-Egbeyemi J, Carter H, Robin C. Thematic analysis of national online narratives on regular asymptomatic testing for Covid-19 in schools in England. BMC Public Health. 2023;23(1):1–13.
doi: 10.1186/s12889-023-15991-3
Yılmaz M, Sahin MK. Parents’ willingness and attitudes concerning the COVID-19 vaccine: a cross‐sectional study. Int J Clin Pract. 2021;75(9):e14364.
pubmed: 33998108 doi: 10.1111/ijcp.14364
Robin C, Symons C, Carter H. Rapid thematic analysis of community social and online media in response to mass asymptomatic COVID-19 testing in Liverpool, England. 2021.
Cunningham-Burley S, Backett‐Milburn K, Kemmer D. Constructing health and sickness in the context of motherhood and paid work. Sociol Health Illn. 2006;28(4):385–409.
pubmed: 16669805 doi: 10.1111/j.1467-9566.2006.00498.x
Popay J, Williams G, Thomas C, Gatrell T. Theorising inequalities in health: the place of lay knowledge. Sociol Health Illn. 1998;20(5):619–44.
doi: 10.1111/1467-9566.00122
Carter H, Drury J, Amlôt R. Social identity and intergroup relationships in the management of crowds during mass emergencies and disasters: recommendations for emergency planners and responders. Policing: J Policy Pract. 2020;14(4):931–44.
doi: 10.1093/police/pay013
Carter H, Weston D, Amlôt R, Haslam S, Cruwys T. Managing crowds in crises. Together Apart: Psychol COVID-19. 2020;13:88–92.
Blake H, Knight H, Jia R, Corner J, Morling JR, Denning C, et al. Students’ views towards Sars-Cov-2 mass asymptomatic testing, social distancing and self-isolation in a university setting during the COVID-19 pandemic: a qualitative study. Int J Environ Res Public Health. 2021;18(8):4182.
pubmed: 33920908 pmcid: 8071290 doi: 10.3390/ijerph18084182
Rotheram S, Health Protection Research Unit GI Annual Scientific Conference. 2023. Challenges recruiting to a study to understand inequalities in the impact of exclusion due to Shiga-toxin producing E.coli (STEC) infection for families with young children in England. [ http://hprugi.nihr.ac.uk/media/3zjhz00r/31-suzie-rotheram.pdf

Auteurs

Amoolya Vusirikala (A)

UK Health Security Agency, London, England, UK. amoolya.vusirikala@ukhsa.gov.uk.
UK Field Epidemiology Training Programme, UK Health Security Agency, London, England, UK. amoolya.vusirikala@ukhsa.gov.uk.
UK Health Security Agency, London, England, UK.
NIHR Health Protection Research Unit in Gastrointestinal Infections, Liverpool, England, UK.

Charlotte Robin (C)

UK Health Security Agency, London, England, UK.

Sam Rowell (S)

UK Health Security Agency, London, England, UK.

Girija Dabke (G)

UK Health Security Agency, London, England, UK.

Georgina Fox (G)

UK Health Security Agency, London, England, UK.

Jade Bell (J)

UK Health Security Agency, London, England, UK.

Rohini Manuel (R)

UK Health Security Agency, London, England, UK.
NIHR Health Protection Research Unit in Gastrointestinal Infections, Liverpool, England, UK.

Claire Jenkins (C)

UK Health Security Agency, London, England, UK.
NIHR Health Protection Research Unit in Gastrointestinal Infections, Liverpool, England, UK.

Nicola K Love (NK)

UK Health Security Agency, London, England, UK.
NIHR Health Protection Research Unit in Gastrointestinal Infections, Liverpool, England, UK.

Noel McCarthy (N)

NIHR Health Protection Research Unit in Gastrointestinal Infections, Liverpool, England, UK.
School of Medicine, Trinity College Dublin, Dublin, Ireland.
Warwick Medical School, School of Medicine, Warwick, England, UK.

Dana Sumilo (D)

NIHR Health Protection Research Unit in Gastrointestinal Infections, Liverpool, England, UK.
Warwick Medical School, School of Medicine, Warwick, England, UK.

Sooria Balasegaram (S)

UK Health Security Agency, London, England, UK.
UK Field Epidemiology Training Programme, UK Health Security Agency, London, England, UK.
NIHR Health Protection Research Unit in Gastrointestinal Infections, Liverpool, England, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH